MRNA Competitors & Alternatives
Compare Moderna Inc with similar stocks in the same industry
Biotechnology
MRNA
Main Stock$195.00
-2.17%
Tradestie Score
44
Market Cap
$10.74B
Revenue Growth
29.2%
Analyst Upside
-15.6%
Supply-Chain & Ecosystem Map (Customers, Suppliers & Direct Competitors)
Bottleneck Score: 6/10
Drug Discovery Biotech
Drug Design
Top Competitors
212 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
VRTX
Vertex Pharmaceuticals Inc
|
$515.02
-1.08%
|
$103.64B | 33.5 | 41 | Compare |
|
REGN
Regeneron Pharmaceuticals Inc
|
$920.69
-0.29%
|
$63.59B | 20.4 | 45 | Compare |
|
ALNY
Alnylam Pharmaceuticals, Inc.
|
$143.82
-2.71%
|
$60.38B | 7.5 | 63 | Compare |
|
ARGX
argenx SE American Depositary Shares
|
$925.70
-1.73%
|
$46.96B | 32.6 | 50 | Compare |
|
ONC
BeOne Medicines Ltd. American Depositary Shares
|
$390.94
-2.19%
|
$36.81B | 51.2 | 49 | Compare |
|
INSM
Insmed, Inc.
|
$141.33
-2.17%
|
$31.13B | - | 39 | Compare |
|
BNTX
BioNTech SE American Depositary Share
|
$80.96
-0.52%
|
$24.57B | - | 44 | Compare |
|
ZM
Zoom Communications, Inc. Class A Common Stock
|
$81.26
-3.05%
|
$24.33B | 7.8 | 45 | Compare |
|
GMAB
Genmab A/S ADS
|
$50.60
-1.46%
|
$19.56B | 43.9 | 42 | Compare |
|
NIO
NIO Inc. American depositary shares, each representing one Class A ordinary share
|
$2.45
-7.89%
|
$18.85B | - | 44 | Compare |
More MRNA Analysis
Data updated: Nov 21, 2026 | Industry: Biotechnology (SIC 2836)
212 stocks in this industry